Advances in Pulmonology and Lung Surgery

Among the top pulmonology & lung surgery hospitals in New York and the country.

Our program is led by renowned physicians and a comprehensive multidisciplinary team. With expert leadership, a strong research component, and unsurpassed patient survival rates, our lung transplantation program has been top-ranked in the Nation for the past 10 years.

3D illustration of non-small cell lung cancer
Oncology, Pulmonology

New Study Finds That Low-Dose Radiation Boosts Effectiveness of Neoadjuvant Immunotherapy for Early-Stage Lung Cancer

Weill Cornell Medicine surgeons report findings of novel study assessing durvalumab plus stereotactic radiation for operable non-small cell lung cancer.

bronchoscopy image

Q&A: Dr. Oliver Chow on the Complexities of Treating Tracheobronchomalacia

Weill Cornell Medicine thoracic surgeon discusses the underrecognized disorder and how a multidisciplinary team treated TBM patient Arlene Packles to give her an improved quality of life.

CT image showing interstitial lung abnormalities

Identifying Interstitial Lung Abnormalities to Prevent Progression to Pulmonary Fibrosis

Weill Cornell Medicine pulmonologist advocates for awareness of ILAs among physicians and outlines potential approach to clinical trials for pulmonary fibrosis prevention.

digital Illustration of respiratory system
Cardiology, Pulmonology

Study Finds Women with COPD Are Not Receiving Recommended Statin Treatment

Weill Cornell Medicine physicians explore health disparities in the treatment of cardiovascular disease among patients with chronic obstructive pulmonary disease.

digital Illustration of lung cancer in red on blue outline of the body

Seminal Study Alters How Non-Small-Cell Lung Cancer is Treated Across the Globe

Weill Cornell Medicine thoracic surgeon shares advancing treatment approaches for non-small-cell lung cancer.

image of chest x-ray of inflamed lung tissue

Measuring Fatigue in Interstitial Lung Disease: Physicians Validate Fatigue Severity Scale

A Weill Cornell Medicine pulmonologist is putting patient centered outcomes, such as fatigue, at the forefront of treatment for interstitial lung disease.

Medical illustration showing lung cancer.

Transforming Care: A Minimally Invasive Approach to Lung Biopsy

A Columbia pulmonologist is changing the paradigm of care for patients with lung nodules made possible by the emerging field of interventional pulmonology.

3D illustration of lung anatomy

Plasma EV-miRNAs: Are They Viable Biomarkers of Premature Lung Injury?

A Columbia pulmonologist evaluates the associations of plasma extracellular vesicle-encapsulated microRNAs with lung function that may lead to early identification and treatment of patients at risk of developing lung disease.

CT scan of emphysema in a person living with HIV

Can a Common Antibiotic Slow Progression of Emphysema in Persons with HIV?

Weill Cornell Medicine pulmonologist and infectious disease specialist collaborate on an NIH-funded phase 2 clinical trial to test if doxycycline will slow progression of emphysema in people with HIV.

vector illustration of ECMO

ECMO and Early Mobilization: When is it Feasible and Safe?

A Columbia medical intensivist and specialist in extracorporeal membrane oxygenation presents factors associated with intensity of treatment for patients in cardiopulmonary failure.

Abstract illustration of lungs, molecule structure

Idiopathic Pulmonary Fibrosis: Rare Variants Link a New Gene and Pathway to Disease

Columbia physician-scientists in pulmonology uncover a new gene and a new pathway responsible for the development of IPF.

digital illustration of lugs with red highlights

Pragmatic Trial Design Provides New Structure for Studies in IPF

Weill Cornell Medicine pulmonologist and lead investigator reflects on the completion of the CleanUP-IPF clinical trial as a valid design for studying idiopathic pulmonary fibrosis.

image of three CT scan of lung following COVID-19 with and without abnormalities

COVID-19: Investigating the Persistence of Severe Respiratory Symptoms

Columbia pulmonary and critical care medicine faculty partner with radiologists to study enduring pulmonary consequences in patients following hospitalization for SARS-CoV-2.

image of bacteria Streptococcus pneumoniae, or pneumococcus

An Expert Makes the Case for Pneumococcal Vaccinations

Weill Cornell Medicine pulmonologist leads a comprehensive review of effectiveness and efficacy of the 23-valent polysaccharide vaccine.

image of lung cells damaged by COVID-19 undergoing analysis

Novel Technique Provides Insights into Lung Pathology in COVID-19

Investigators at Weill Cornell Medicine and NewYork-Presbyterian used advanced technology and analytics to map, at single-cell resolution, the cellular landscape of diseased lung tissue in severe COVID-19 and other infectious lung diseases.

vector image of coronavirus

COVID-19: One Year Later

Pulmonologists and critical care medicine specialists at NewYork-Presbyterian Hospital, Columbia University, and Weill Cornell Medicine continue to share their observations and present their research findings on severe acute respiratory syndrome coronavirus 2.

image of Dr. Selim M. Arcasoy

Lung Transplantation: Decades of Experience and Expertise

Since the inception of the new program nearly two decades ago, the Lung Transplantation Program at NewYork-Presbyterian/Columbia has performed more than 900 lung transplants with survival rates that far surpass national averages.

image of Dr. Sanja J. Jelic

Sleep and Cardiovascular Risk: A Causal Relationship?

Sleep is increasingly recognized as an important contributor to health, yet many Americans regularly do not get enough sleep. To learn if inadequate sleep increases their risks of heart disease, NYP Columbia study the relationship between sleep habits and cardiovascular risk factors.

image of Dr. Robert J. Kaner

IPF: Looking to the Microbiome for New Treatments

Despite years of investigations, the origin of idiopathic pulmonary fibrosis has remained elusive. Researchers at NewYork-Presbyterian/Weill Cornell are looking into new therapies to slow the progression.

Newsletters for Medical Professionals

2022 Issue 1

2021 Issue 2

2021 Issue 1

2018 Issue 2

2018 Issue 1

2017 Issue 1

Spring/Summer 2016